Advertisement

Central European Journal of Medicine

, Volume 5, Issue 5, pp 541–543 | Cite as

Intracranial plasmacytoma as an initial presentation of multiple myeloma

  • Alev Akyol Erikci
  • Ozkan Sayan
  • Bulent Karagoz
  • Zafer Kucukodaci
  • Murat Velioglu
Case Report
  • 36 Downloads

Abstract

Intra-cranial involvement is an uncommon complication of multiple myeloma. We report a 68-year-old woman hospitalized for acute renal failure, vertigo and headache. Magnetic Resonance Imaging (MRI) revealed two and a half and 3cm length cranial lesion, which proved to be plasmacytoma. After complete staging, we retained the diagnosis of immunoglobulin G lambda-type multiple myeloma with intracranial involvement. Cytogenetic analysis of plasma cells detected no change. Currently, she is a regular hemodialysis patient. She is planned to have both systemic therapy with 40mg dexamethasone and cranial radiotherapy. Involvement of the CNS in multiple myeloma is very rare. Diagnosis of multiple myeloma subsequent to initial intrcranial involvement is confined to exceptional cases. Despite aggressive systemic treatments, including autologous stem cell transplantation and local treatments such as cerebral radiotherapy, the prognosis for patients with CNS myeloma is extremely poor. Our unique case implies that physicians should be alert in case of vertigo or headache in cases with acute renal failure.

Keywords

Cranial involvement Multiple myeloma Vertigo Headache 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Fassas ABT, Muwalla F, Berryman T, Berryman T, Benramdane R, Joseph, L et al. Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extra-medullary manifestations. Br J Haematol 2002;117;103–108CrossRefPubMedGoogle Scholar
  2. [2]
    Petersen S, Wagner A, Gimsing P. Cerebral and meningeal multiple myeloma after autologous stem cell transplantation. A case report and review of the literature. Am J Hematol 1999;62; 228–233CrossRefPubMedGoogle Scholar
  3. [3]
    Nieuwenhuizen L, Biesma DH. Central nervous system myelomatosis: review of the literature. Eur J Haematol. 2008;80; 1–9PubMedGoogle Scholar
  4. [4]
    Kaplan JG, DeSouza TG, Farkash A, Shafran B, Pack D, Rehman F, Fuks J, Portenoy R. Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas, and leukemias. J Neurooncol 1990;9; 225–229CrossRefPubMedGoogle Scholar

Copyright information

© © Versita Warsaw and Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  • Alev Akyol Erikci
    • 1
  • Ozkan Sayan
    • 1
  • Bulent Karagoz
    • 2
  • Zafer Kucukodaci
    • 3
  • Murat Velioglu
    • 4
  1. 1.Departments of HematologyGATA Haydarpasa Training HospitalIstanbulTurkey
  2. 2.Departments of OncologyGATA Haydarpasa Training HospitalIstanbulTurkey
  3. 3.Departments of PathologyGATA Haydarpasa Training HospitalIstanbulTurkey
  4. 4.Departments of RadiologyGATA Haydarpasa Training HospitalIstanbulTurkey

Personalised recommendations